Start-Ups Shaking Things Up in Health Sector at MEDICA
|
By LabMedica International staff writers Posted on 22 Jun 2023 |
|
The internationally leading medical trade fair MEDICA (Düsseldorf, Germany) has long been recognized as a global platform for health sector startups. At the forthcoming MEDICA 2023, which will be running concurrently with the professional suppliers' trade fair COMPAMED 2023 from 13-16 November, hundreds of new developer teams will be present among more than 5,000 exhibiting companies to seek collaborations related to funding, production, product approval, marketing, and sales. The event boasts a number of program highlights geared towards startups, providing them with an optimal platform for introducing their innovative solutions to the international professional healthcare community. Notable program highlights include the 12th MEDICA Startup Competition, the 15th Healthcare Innovation World Cup, the MEDICA START-UP PARK, and numerous startup exhibitions at the MEDICA CONNECTED HEALTHCARE FORUM.
The MEDICA Startup Competition places emphasis on a wide array of healthcare innovations, ranging from artificial intelligence (AI) and health apps to laboratory diagnostics and medical robotics. This year, "Sustainability" is being introduced as a new category. The 2022 winner of the competition was a Spanish startup, Idoven, which has developed an AI-based platform for cardiology-as-a-service. Idoven's proprietary AI enhances the accuracy and consistency of electrocardiograph (ECG) interpretations. Their participation in the competition offered the company immense global visibility and attracted around USD 20 million in funding for future projects and developments.
The 15th Healthcare Innovation World Cup could be another interesting opportunity for startups, scale-ups, and smaller mid-level companies. It focuses on smart Internet of Medical Things (IoMT) solutions, such as digital biomarkers, smart band-aids, or wearables with network connectivity. The 12 selected finalists will be invited to showcase their businesses at MEDICA 2023 on the MEDICA CONNECTED HEALTHCARE FORUM stage. Last year's winner was ViewMind Inc., a company specializing in management of neurodegenerative diseases.
The MEDICA START-UP PARK has become a central hub for startup networking, already attracting a record 40 early registrations this year. A repeat participant is the Ukrainian start-up initiative "Up To Future," promoting startups such as HandyUsound, which developed a portable ultrasound system. Also participating is Korea's Megnosis, the creator of EEG helmets designed to detect dementia early and stimulate brain cells and neurons. Among German participants is AssistMe, which will introduce a smart sensor system for use in underwear for incontinence at MEDICA 2023.
“I was very surprised at how global this trade fair is!” said Rika Christanto, COO at Idoven, who is pleased with the effect of participating at MEDICA and the competition finals on the stage of the MEDICA CONNECTED HEALTHCARE FORUM.
Related Links:
MEDICA
Latest Business News
Channels
Clinical Chemistry
view channel
Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
Molecular Diagnostics
view channel
First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more
New Molecular Label to Help Develop Simpler and Faster Tuberculosis Tests
Tuberculosis (TB), the deadliest infectious disease globally, is responsible for infecting an estimated 10 million people each year and causing over 1 million deaths annually. While chest X-rays and molecular... Read more
Biomarker Discovery Paves Way for Blood Tests to Detect and Treat Osteoarthritis
The number of individuals affected by osteoarthritis is projected to exceed 1 billion by 2050. The primary risk factor for this common, often painful chronic joint condition is aging, and, like aging itself,... Read more
Hematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read more
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Pathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read more
Technology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
